BEULQUE, Yana et al. Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab. Acta Oncologica, [S. l.], v. 63, n. 1, p. 658–668, 2024. DOI: 10.2340/1651-226X.2024.40390. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/40390. Acesso em: 16 feb. 2025.